Sonoma Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 19.94 K | $42.47 K | 25.35% | 1.16% |
| 05/15/2026 | 18.79 K | $40.02 K | 100.00% | 1.10% | |
| DRW SECURITIES, LLC | 05/13/2026 | 12.02 K | $25.59 K | -80.30% | 0.70% |
| MCKINLEY CARTER WEALTH SERVICES, INC. | 04/20/2026 | 11.19 K | $23.84 K | 0.00% | 0.65% |
| MORGAN STANLEY | 05/15/2026 | 2.00 K | $4.27 K | 50,000.00% | 0.12% |
| CITIGROUP INC | 05/11/2026 | 1.43 K | $3.04 K | 100.00% | 0.08% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.23 K | $2.62 K | 219.74% | 0.07% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 500 | $1.07 K | 0.00% | 0.03% |
| JPMORGAN CHASE & CO | 05/13/2026 | 123 | $255 | 1.65% | 0.01% |
| BLACKROCK, INC. | 05/13/2026 | 113 | $241 | 0.00% | 0.01% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 100 | $213 | 100.00% | 0.01% |
| US BANCORP \DE\ | 05/15/2026 | 25 | $53 | 0.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 6 | $13 | 0.00% | 0.00% |
| QUAKER WEALTH MANAGEMENT, LLC | 04/10/2026 | 3 | $7 | 0.00% | 0.00% |
| DANSKE BANK A/S | 05/12/2026 | 1 | $2 | 0.00% | 0.00% |
| CWM, LLC | 05/14/2026 | 1 | $2 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 1 | $2 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sonoma Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Sonoma Pharmaceuticals Inc.. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 19,941
DRW Securities, LLC: 12,015
McKinley Carter Wealth Services, Inc.: 11,193
MORGAN STANLEY: 2,004
CITIGROUP INC: 1,425
Tower Research Capital LLC (TRC): 1,231
3.94% of Sonoma Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.77 K shares in the last 24 months. This purchase volume represents approximately $178.35 K in transactions.